Eisler Capital (Uk) Ltd. Abb Vie Inc. Put Options Transaction History

Eisler Capital (Uk) Ltd.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $32.2 Million - $39.1 Million	196,325 Added 41.03%	674,863 $133 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $20.2 Million - $23.6 Million	130,568 Added 37.52%	478,538 $82.1 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $6.69 Million - $7.62 Million	41,867 Added 13.68%	347,970 $63.4 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $31.7 Million - $35.7 Million	230,119 Added 302.85%	306,103 $47.4 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $10.2 Million - $11.8 Million	75,984 New	75,984 $11.3 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $11.6 Million - $14.7 Million	-84,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $9.03 Million - $11.4 Million	84,100 New	84,100 $11.4 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.